|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 44,48 BRL | +0,45% |
|
-.--% | +10,32% |
| 31/07 | NEUROCRINE BIOSCIENCES, INC. : RBC Capital Markets réitère son opinion positive sur le titre | ZM |
| 31/07 | NEUROCRINE BIOSCIENCES, INC. : Deutsche Bank Securities n'est pas inspiré par le dossier | ZM |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Varia. | Varia. 5j. | Variation 1 mois | Variation 3 mois | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Varia. 5ans | Varia. 10ans | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0,53% | -3,95% | -5,36% | +19,26% | +6,90% | +50,70% | +152,78% | +365,87% | +1 278,83% | 1 024 Md | |
| +0,21% | -2,68% | -2,54% | +12,84% | +23,87% | +53,20% | +50,87% | +48,81% | +105,33% | 618 Md | |
| -2,51% | -3,25% | -3,88% | +21,46% | +9,83% | +28,54% | +67,99% | +117,36% | +275,77% | 443 Md | |
| +0,06% | -0,42% | +3,54% | +11,06% | +7,74% | +37,53% | +31,06% | +0,48% | +44,09% | 349 Md | |
| -0,14% | -0,24% | -1,11% | +9,23% | +15,51% | +34,41% | +39,49% | +51,13% | +58,95% | 297 Md | |
| -0,69% | -0,30% | -13,11% | -6,51% | -8,40% | +13,76% | +13,84% | +52,67% | +152,54% | 264 Md | |
| -7,37% | -4,40% | -7,68% | +10,25% | -5,76% | -0,74% | -43,66% | +5,53% | +65,45% | 209 Md | |
| -0,64% | +2,43% | +2,94% | +16,78% | +17,67% | +29,74% | +67,16% | +60,62% | +121,17% | 208 Md | |
| -0,82% | +0,70% | -0,81% | -1,09% | +6,09% | +15,05% | +72,05% | +90,50% | +63,64% | 162 Md | |
| +0,40% | +1,92% | +2,84% | -5,01% | +0,44% | +6,47% | -29,25% | -43,11% | -31,27% | 143 Md | |
| +0,69% | +5,19% | +12,35% | +12,18% | +21,08% | +47,66% | +5,77% | -3,98% | -12,98% | 133 Md | |
| -0,95% | -0,05% | -9,65% | +12,54% | +5,24% | +3,24% | +33,12% | +140,57% | +381,24% | 121 Md | |
| -0,44% | +0,63% | -3,62% | +1,60% | +5,86% | +38,31% | +41,25% | +8,24% | -8,57% | 104 Md | |
| +2,34% | -2,05% | -1,04% | -6,70% | -9,97% | -7,31% | -21,50% | -14,16% | +0,76% | 103 Md | |
| -4,21% | -3,04% | -13,11% | -17,97% | -19,45% | -9,08% | +59,92% | +65,83% | +436,93% | 71,57 Md | |
| -3,14% | -7,44% | -0,35% | +0,56% | +10,44% | +26,57% | +22,39% | +46,22% | +13,09% | 55,24 Md | |
| -0,81% | +4,32% | -9,95% | +26,28% | +29,83% | +70,87% | -7,60% | -4,87% | -48,99% | 54,3 Md | |
| -1,04% | +1,18% | +1,10% | +0,37% | -9,22% | -11,79% | +27,91% | -2,12% | +232,84% | 52,81 Md | |
| -1,44% | -0,06% | +0,80% | +5,58% | -3,07% | -0,57% | +12,95% | - | - | 43,08 Md | |
| Moyenne | -1,11% | -0,54% | -2,56% | +6,46% | +5,51% | +22,45% | +31,40% | +54,76% | +173,82% | 234,45 Md | |
| Moyenne pondérée par Capi. | -0,88% | -1,63% | -3,02% | +11,19% | +8,53% | +33,18% | +60,76% | +120,43% | +385,47% |
- Bourse
- Actions
- Action NBIX
- Action N1BI34
- Secteur Neurocrine Biosciences, Inc.
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
